The objective of this study is to explore and validate a novel prognostic index for patients with locally advanced or metastatic biliary tract cancer (BTC) treated with first‐line therapy with cisplatin, gemcitabine, and durvalumab.
M. Persano, A. Casadei-Gardini, L. Fornaro et al.· Cancer· 0 citations
Summary The management of unresectable and advanced hepatocellular carcinoma (HCC) has been transformed by the introduction of immune checkpoint inhibitor-based combinations, which have improved response and survival and expanded first-line treatment options. The availability of multiple effective regimens has introduc...
D. Pinato, E. Alimenti, Pasquale Lombardi et al.· The Lancet Regional Health -...· 1 citation
Pre-existing CLD is associated with earlier-stage CCA diagnosis and improved survival, supporting the implementation of structured surveillance strategies in high-risk CLD populations and highlighting the need to optimize strategies for selected moderate-to-high risk CLD populations.
L. Izquierdo-Sánchez, J. Narbaiza, Julen Martin-Robles et al.· Journal of Hepatology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.